enVVeno Medical (NVNO) News Today $3.49 +0.20 (+6.08%) As of 01/21/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Insider Buying: enVVeno Medical Corporation (NASDAQ:NVNO) Director Acquires 3,500 Shares of StockJanuary 3, 2025 | insidertrades.comenVVeno Medical Corporation (NASDAQ:NVNO) Director Robert Gray Buys 3,500 SharesenVVeno Medical Corporation (NASDAQ:NVNO - Get Free Report) Director Robert Gray bought 3,500 shares of the business's stock in a transaction dated Tuesday, December 31st. The shares were bought at an average price of $2.94 per share, with a total value of $10,290.00. Following the purchase, the director now owns 11,155 shares in the company, valued at $32,795.70. The trade was a 45.72 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.January 2, 2025 | marketbeat.comInsider Buying: enVVeno Medical Corporation (NASDAQ:NVNO) Director Purchases 5,400 Shares of StockDecember 27, 2024 | insidertrades.comenVVeno Medical Corporation (NASDAQ:NVNO) Director Acquires $15,660.00 in StockenVVeno Medical Corporation (NASDAQ:NVNO - Get Free Report) Director Sanjay Shrivastava purchased 5,400 shares of the firm's stock in a transaction dated Tuesday, December 24th. The shares were bought at an average cost of $2.90 per share, for a total transaction of $15,660.00. Following the completion of the purchase, the director now directly owns 9,288 shares of the company's stock, valued at $26,935.20. The trade was a 138.89 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.December 26, 2024 | marketbeat.comenVVeno Medical Corporation (NASDAQ:NVNO) Director Acquires $24,338.60 in StockDecember 24, 2024 | insidertrades.comenVVeno Medical Corporation: enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVeDecember 16, 2024 | finanznachrichten.deenVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH SymposiumNovember 20, 2024 | finance.yahoo.comenVVeno Medical Corporation: enVVeno Medical Submits the VenoValve PMA Application Seeking FDA ApprovalNovember 19, 2024 | finanznachrichten.deenVVeno Medical reports Q3 EPS (35c) vs. (45c) last yearNovember 1, 2024 | markets.businessinsider.comenVVeno Medical expects capital to fund company through several milestonesNovember 1, 2024 | markets.businessinsider.comenVVeno Medical Successfully Initiates 6-Month Pre-Clinical GLP Study Evaluating enVVe(R)October 28, 2024 | finance.yahoo.comAVITA Medical Headed For Its Most Important Report, I'm Extremely BullishOctober 2, 2024 | seekingalpha.comBioMedNewsBreaks — enVVeno Medical Corporation (NASDAQ: NVNO) Announces Pricing of $15M Underwritten Public OfferingOctober 1, 2024 | msn.comenVVeno Medical (NASDAQ:NVNO) Stock Quotes, Forecast and News SummarySeptember 28, 2024 | benzinga.comCrude Oil Rises; Onconetix Shares Spike HigherSeptember 27, 2024 | msn.comCassava Sciences, enVVeno Medical And Other Big Stocks Moving Lower In Friday's Pre-Market SessionSeptember 27, 2024 | msn.comEnVVeno Medical Announces Pricing Of Public Offering - Quick FactsSeptember 27, 2024 | markets.businessinsider.comenVVeno Medical Corporation Announces Proposed Public OfferingSeptember 27, 2024 | finance.yahoo.comenVVeno Medical Corporation: enVVeno Medical Adds Sandy Prietto to its Executive Team as Vice President of MarketingSeptember 4, 2024 | finanznachrichten.deVanguard Group Inc. Buys 237,550 Shares of enVVeno Medical Corporation (NASDAQ:NVNO)Vanguard Group Inc. raised its position in shares of enVVeno Medical Corporation (NASDAQ:NVNO - Free Report) by 70.6% in the first quarter, according to its most recent filing with the SEC. The firm owned 573,955 shares of the company's stock after purchasing an additional 237,550 shares during theAugust 19, 2024 | marketbeat.comenVVeno Medical Corporation Registered ShsJuly 19, 2024 | markets.businessinsider.comKingdon Capital Management L.L.C. Purchases 400,000 Shares of enVVeno Medical Corporation (NASDAQ:NVNO)Kingdon Capital Management L.L.C. increased its holdings in shares of enVVeno Medical Corporation (NASDAQ:NVNO - Free Report) by 182.5% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 619,180 shares of the company's stock after purchasing an additional 40June 17, 2024 | marketbeat.comenVVeno Medical Corporation (NASDAQ:NVNO) Stake Lessened by Perceptive Advisors LLCPerceptive Advisors LLC trimmed its stake in shares of enVVeno Medical Corporation (NASDAQ:NVNO - Free Report) by 20.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 623,315 shares of the company's stock after sellinJune 16, 2024 | marketbeat.comArmistice Capital LLC Invests $2.24 Million in enVVeno Medical Corporation (NASDAQ:NVNO)Armistice Capital LLC purchased a new position in enVVeno Medical Corporation (NASDAQ:NVNO - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 436,000 shares of the company's stock, valued at approximatelyJune 6, 2024 | marketbeat.comenVVeno Medical (NASDAQ:NVNO) Trading Down 1.8%enVVeno Medical (NASDAQ:NVNO) Trading Down 1.8%May 22, 2024 | marketbeat.comNVNO Stock Earnings: enVVeno Medical Beats EPS for Q1 2024May 9, 2024 | msn.comenVVeno Medical Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 8, 2024 | finance.yahoo.comenVVeno Medical Corporation (NVNO)April 24, 2024 | finance.yahoo.comPositive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve(R) Pivotal Trial to be Presented Today at the 46th Annual Charing Cross SymposiumApril 24, 2024 | finance.yahoo.comNew Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024April 16, 2024 | finance.yahoo.comenVVeno Medical hires new CCO to guide transitionApril 11, 2024 | uk.investing.comenVVeno Medical Corporation: enVVeno Medical Appoints Andrew Cormack as Its Chief Commercial OfficerApril 10, 2024 | finanznachrichten.deenVVeno Medical Appoints Andrew Cormack as Its Chief Commercial OfficerApril 9, 2024 | finance.yahoo.comenVVeno Medical Corporation (NASDAQ:NVNO) CTO Hamed Alavi Sells 8,334 SharesMarch 16, 2024 | insidertrades.comNVNO Apr 2024 10.000 callMarch 16, 2024 | finance.yahoo.comenVVeno Medical to Participate in the Virtual Investor Lunch Break: The enVVeno OpportunityMarch 15, 2024 | finance.yahoo.comPositive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual MeetingMarch 6, 2024 | finance.yahoo.comCompanies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In GrowthMarch 3, 2024 | finance.yahoo.comenVVeno Medical Corporation: enVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate UpdateFebruary 29, 2024 | finanznachrichten.deRecap: enVVeno Medical Q4 EarningsFebruary 29, 2024 | benzinga.comenVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate UpdateFebruary 29, 2024 | finance.yahoo.comTopline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the VENOUS2024 American Venous Forum Annual Meeting on March 6, 2024February 20, 2024 | finance.yahoo.comenVVeno Medical (NVNO) Scheduled to Post Quarterly Earnings on MondayenVVeno Medical (NASDAQ:NVNO) will be releasing earnings on Monday, February 5, Yahoo Finance reports.February 4, 2024 | marketbeat.comenVVeno Medical Corporation's (NASDAQ:NVNO) Path To ProfitabilityJanuary 6, 2024 | finance.yahoo.comNVNO Jan 2024 5.000 callDecember 29, 2023 | ca.finance.yahoo.comenVVeno Medical Corporation: enVVeno Medical Posts Company Highlights and Materials from 2023 VEITH SymposiumDecember 14, 2023 | finanznachrichten.deenVVeno Medical Posts Company Highlights and Materials from 2023 VEITH SymposiumDecember 14, 2023 | finance.yahoo.comenVVeno Medical Presents Positive Preliminary Device Related Material Adverse Event (MAE) Data from the VenoValve Pivotal Trial at the 50th Annual VEITH SymposiumNovember 16, 2023 | finance.yahoo.comenVVeno Medical Corporation: enVVeno Medical Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateOctober 26, 2023 | finanznachrichten.deenVVeno Medical files to sell 14.71M shares for holdersOctober 26, 2023 | msn.com Get enVVeno Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter. Email Address NVNO Media Mentions By Week NVNO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVNO News Sentiment▼0.000.63▲Average Medical News Sentiment NVNO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVNO Articles This Week▼00▲NVNO Articles Average Week Get enVVeno Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PROF News UTMD News OBIO News SKIN News KRMD News BWAY News INFU News SGHT News NVRO News PDEX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVNO) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding enVVeno Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share enVVeno Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
